.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Understanding the biological markers of neurodevelopmental conditions remains a priority for clinicians in India and globally. A recent study investigating digit ratios in autism has provided surprising results that challenge long-standing hypotheses. Researchers examined 25 boys with classic autism alongside 57 age-matched controls. They aimed to determine if prenatal androgen exposure influences finger length patterns in a predictable way.
The "Extreme Male Brain" theory suggests that children with autism spectrum disorder (ASD) experience high levels of prenatal testosterone. Consequently, scientists often look at the 2D:4D ratio as an anatomical marker of this exposure. Specifically, a lower ratio typically indicates higher testosterone levels during gestation. However, this study found that boys with ASD actually displayed a female-like finger growth pattern. Therefore, the data do not support theories suggesting excessive fetal testosterone in these cases.
The findings indicate a demasculinized pattern of finger differentiation rather than the predicted hypermasculine one. This discrepancy highlights the complexity of digit ratios in autism as a diagnostic or research tool. Furthermore, it suggests that other factors beyond simple androgenization may contribute to the ASD phenotype. Researchers utilized digital imaging and validated measurement protocols to ensure accuracy. These results encourage a broader perspective on the neurodevelopmental origins of autism.
Digit ratios, particularly the 2D:4D ratio, are thought to reflect prenatal hormone exposure. While some theories predict masculinized ratios in autism, this recent evidence shows demasculinized or female-like patterns in certain cohorts.
No, finger ratios are not diagnostic tools. They are currently used in research to understand potential biological influences during fetal development. Clinical diagnosis remains based on behavioral and developmental criteria as per the DSM-5.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study finds that boys with autism show a female-like finger growth pattern, contradicting the hypermasculine theory of prenatal testosterone exposure....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
